Stephan Dietrich A 4
4 · NeuBase Therapeutics, Inc. · Filed Jan 25, 2022
Insider Transaction Report
Form 4
Stephan Dietrich A
DirectorPresident and CEO10% Owner
Transactions
- Award
Employee Stock option (right to buy)
2022-01-24+306,000→ 306,000 totalExercise: $1.58Exp: 2032-01-24→ Common Stock (306,000 underlying)
Footnotes (1)
- [F1]25% of the total shares shall vest on the first anniversary of January 24, 2022, and the remaining shares shall vest on an equal monthly basis over the following 36 months; provided that vesting shall only occur on a scheduled vesting date if employment has not terminated prior to such vesting date.